tirzepatide forum At a for @GRT Tirzepatide on ingestive behavior in
Description
Body-composition research models
Petrelintide, a long-acting amylin analog, is being tested in Phase II trials and may offer improved tolerability and sustained weight loss.
Explore pharmacokinetic and anti-drug antibody (ADA) assessment strategies for GLP-1 receptor agonists in this expert-led whitepaper from Aragen.
Results Reducing dose frequency does not commensurately reduce weight loss
Middlesboro, KY
With the news that consumer food spending is in decline, attributed to the growing popularity of Ozempic and other similar medications, we dive into the impact of GLP-1 on the food industry
